首页> 外文期刊>Reviews in gynaecological practice >Morbidity of abdominal myomectomy: Dispelling the myth
【24h】

Morbidity of abdominal myomectomy: Dispelling the myth

机译:腹部肌瘤切除术的发病率:消除神话

获取原文
获取原文并翻译 | 示例
           

摘要

Abdominal myomectomy is the commonest conservative surgical procedure offered to patients with symptomatic fibroids and as a fertility enhancing procedure to some women with large intramural fibroids when no other cause for subfertility is evident. Historically myomectomy has been considered to be a complex procedure with high risk of complications. However, there is no evidence to support this assumption and recent studies have shown that the morbidity of myomectomy and hysterectomy is comparable. In recent times, new treatment strategies with a minimally invasive approach have evolved but are available only in selected centres and their efficacy has not been evaluated in the light of well-designed research trials. Therefore, myomectomy remains the mainstay of surgical treatment in women who wish to retain their uterus. This review aims to dispel the misconceptions about morbidity of myomectomy and provides an evidence-based account of the measures that can be taken to minimise it.
机译:腹部肌瘤切除术是对有症状的肌瘤患者提供的最常见的保守手术方法,并且在没有其他原因引起的不育症的情况下,对于某些具有较大壁内肌瘤的女性来说,是一种增强生育力的方法。从历史上看,子宫肌瘤切除术被认为是具有高并发症风险的复杂手术。但是,没有证据支持这一假设,最近的研究表明子宫肌瘤切除术和子宫切除术的发病率具有可比性。近年来,采用微创方法的新治疗策略已经发展,但仅在部分中心可用,并且尚未根据精心设计的研究试验评估其疗效。因此,子宫肌瘤切除术仍然是希望保留子宫的女性外科治疗的主要手段。这篇综述旨在消除对子宫肌瘤切除术发病率的误解,并为减少该肌瘤切除术的措施提供了循证证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号